{
    "2020-11-20": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Why Mesoblast Stock Is Blasting Off Today",
                "features": {
                    "keywords": [
                        "Mesoblast",
                        "Blasting Off",
                        "Today"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Novartis (NVS) Partners With Mesoblast for ARDS Cell Therapy",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Partners",
                        "Mesoblast",
                        "ARDS",
                        "Cell Therapy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "PFE",
                        "COVID-19",
                        "Vaccine",
                        "Final Analysis",
                        "FDA Updates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "20 Largest European Companies By Market Cap in 2020",
                "features": {
                    "keywords": [
                        "Largest",
                        "European",
                        "Companies",
                        "Market Cap",
                        "2020"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger",
                "features": {
                    "keywords": [
                        "Daily Biotech Pulse",
                        "Amarin",
                        "Surges",
                        "Vascepa Data",
                        "Mesoblast",
                        "Rallies",
                        "Novartis Deal",
                        "Decision Day",
                        "Eiger"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}